Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020–October 2021

BACKGROUND: We determined circulating anti-S severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody titers in a vaccinated healthcare workers (HCWs) cohort from Northern Israel in the 11 months following primary vaccination according to age, ethnicity, and previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Edelstein, Michael, Wiegler Beiruti, Karine, Ben-Amram, Hila, Bar-Zeev, Naor, Sussan, Christian, Asulin, Hani, Strauss, David, Bathish, Younes, Zarka, Salman, Abu Jabal, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992305/
https://www.ncbi.nlm.nih.gov/pubmed/35279028
http://dx.doi.org/10.1093/cid/ciac212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992305/
https://www.ncbi.nlm.nih.gov/pubmed/35279028
http://dx.doi.org/10.1093/cid/ciac212

Ejemplares similares